849 related articles for article (PubMed ID: 27710868)
1. Efficacy and tolerability of brivaracetam compared to lacosamide, eslicarbazepine acetate, and perampanel as adjunctive treatments in uncontrolled focal epilepsy: Results of an indirect comparison meta-analysis of RCTs.
Brigo F; Bragazzi NL; Nardone R; Trinka E
Seizure; 2016 Nov; 42():29-37. PubMed ID: 27710868
[TBL] [Abstract][Full Text] [Related]
2. A common reference-based indirect comparison meta-analysis of eslicarbazepine versus lacosamide as add on treatments for focal epilepsy.
Brigo F; Trinka E; Bragazzi NL; Nardone R; Milan A; Grillo E
Epilepsy Res; 2016 Nov; 127():12-18. PubMed ID: 27543806
[TBL] [Abstract][Full Text] [Related]
3. Indirect comparison of third-generation antiepileptic drugs as adjunctive treatment for uncontrolled focal epilepsy.
Li-Na Z; Deng C; Hai-Jiao W; Da X; Ge T; Ling L
Epilepsy Res; 2018 Jan; 139():60-72. PubMed ID: 29197667
[TBL] [Abstract][Full Text] [Related]
4. Third-Generation Antiseizure Medications for Adjunctive Treatment of Focal-Onset Seizures in Adults: A Systematic Review and Network Meta-analysis.
Lattanzi S; Trinka E; Zaccara G; Striano P; Russo E; Del Giovane C; Silvestrini M; Brigo F
Drugs; 2022 Feb; 82(2):199-218. PubMed ID: 35061214
[TBL] [Abstract][Full Text] [Related]
5. Newer antiepileptic drugs compared to levetiracetam as adjunctive treatments for uncontrolled focal epilepsy: An indirect comparison.
Zhu LN; Chen D; Xu D; Tan G; Wang HJ; Liu L
Seizure; 2017 Oct; 51():121-132. PubMed ID: 28854405
[TBL] [Abstract][Full Text] [Related]
6. Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine.
Zaccara G; Giovannelli F; Maratea D; Fadda V; Verrotti A
Seizure; 2013 Sep; 22(7):528-36. PubMed ID: 23623245
[TBL] [Abstract][Full Text] [Related]
7. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
[TBL] [Abstract][Full Text] [Related]
8. Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial.
Kwan P; Trinka E; Van Paesschen W; Rektor I; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):38-46. PubMed ID: 24116853
[TBL] [Abstract][Full Text] [Related]
9. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.
Ryvlin P; Werhahn KJ; Blaszczyk B; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):47-56. PubMed ID: 24256083
[TBL] [Abstract][Full Text] [Related]
10. A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study.
Roberti R; Di Gennaro G; Anzellotti F; Arnaldi D; Belcastro V; Beretta S; Boero G; Bonanni P; Canafoglia L; D'Aniello A; Dainese F; De Caro C; Di Gennaro G; Di Giacomo R; DiFrancesco JC; Dono F; Falcicchio G; Ferlazzo E; Foschi N; Franciotta S; Gambardella A; Giordano A; Iannone LF; Labate A; La Neve A; Lattanzi S; Leggio U; Liguori C; Maschio M; Nilo A; Operto FF; Pascarella A; Pauletto G; Renna R; Strigaro G; ; Russo E
Epilepsia; 2024 Feb; 65(2):456-472. PubMed ID: 38052481
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive brivaracetam for patients with refractory partial seizures: A meta-analysis of randomized placebo-controlled trials.
Ma J; Huang S; You C
Epilepsy Res; 2015 Aug; 114():59-65. PubMed ID: 26088886
[TBL] [Abstract][Full Text] [Related]
12. Effect of lifetime antiepileptic drug treatment history on efficacy and tolerability of adjunctive brivaracetam in adults with focal seizures: Post-hoc analysis of a randomized, placebo-controlled trial.
Klein P; McLachlan R; Foris K; Nondonfaz X; Elmoufti S; Dimova S; Brandt C
Epilepsy Res; 2020 Nov; 167():106369. PubMed ID: 32717713
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures.
Klein P; Schiemann J; Sperling MR; Whitesides J; Liang W; Stalvey T; Brandt C; Kwan P
Epilepsia; 2015 Dec; 56(12):1890-8. PubMed ID: 26471380
[TBL] [Abstract][Full Text] [Related]
14. Efficacy, safety, and tolerability of adjunctive brivaracetam in adult Asian patients with uncontrolled focal-onset seizures: A phase III randomized, double-blind, placebo-controlled trial.
Inoue Y; Tiamkao S; Zhou D; Cabral-Lim L; Lim KS; Lim SH; Tsai JJ; Moseley B; Wang L; Sun W; Hayakawa Y; Sasamoto H; Sano T; McClung C; Bass A
Epilepsia Open; 2024 Jun; 9(3):1007-1020. PubMed ID: 38576178
[TBL] [Abstract][Full Text] [Related]
15. Value of drug level concentrations of brivaracetam, lacosamide, and perampanel in care of people with epilepsy.
Hentschel M; Stoffel-Wagner B; Surges R; von Wrede R; Dolscheid-Pommerich RC
Epilepsia; 2024 Mar; 65(3):620-629. PubMed ID: 38158709
[TBL] [Abstract][Full Text] [Related]
16. A systematic review and indirect treatment comparison of perampanel versus brivaracetam as adjunctive therapy in patients with focal-onset seizures with or without secondary generalization.
Trinka E; Tsong W; Toupin S; Patten A; Wilson K; Isojarvi J; James D
Epilepsy Res; 2020 Oct; 166():106403. PubMed ID: 32673969
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of adjunctive brivaracetam in adults with uncontrolled partial-onset seizures: a phase IIb, randomized, controlled trial.
Van Paesschen W; Hirsch E; Johnson M; Falter U; von Rosenstiel P
Epilepsia; 2013 Jan; 54(1):89-97. PubMed ID: 22813235
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of brivaracetam at different doses for partial-onset epilepsy: a meta-analysis of placebo-controlled studies.
Tian X; Yuan M; Zhou Q; Wang X
Expert Opin Pharmacother; 2015; 16(12):1755-67. PubMed ID: 26165169
[TBL] [Abstract][Full Text] [Related]
19. Eslicarbazepine acetate add-on therapy for drug-resistant focal epilepsy.
Chang XC; Yuan H; Wang Y; Xu HQ; Hong WK; Zheng RY
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD008907. PubMed ID: 34155624
[TBL] [Abstract][Full Text] [Related]
20. Tolerability, safety, and efficacy of adjunctive brivaracetam for focal seizures in older patients: A pooled analysis from three phase III studies.
Brodie MJ; Whitesides J; Schiemann J; D'Souza J; Johnson ME
Epilepsy Res; 2016 Nov; 127():114-118. PubMed ID: 27589414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
